Skin Cancer Research

Skin Cancer Research

Research into skin cancer at Penn State Cancer Institute is conducted by the melanoma and skin cancer team. See current clinical trials and members of that team here.

Clinical Trials

A Phase II Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Performance of the DecisionDx-Melanoma Gene Expression Profile Test for Prognosis of Recurrence Risk
Definition of Somatic Variants Corresponding to Immune Targets in Patients with Metastatic Melanoma

Disease Team Members

Research into skin cancer at Penn State Cancer Institute is conducted by the melanoma and skin cancer team. See current clinical trials and members of that team here.
A Phase II Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Performance of the DecisionDx-Melanoma Gene Expression Profile Test for Prognosis of Recurrence Risk
Definition of Somatic Variants Corresponding to Immune Targets in Patients with Metastatic Melanoma

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)